加拿大SQI Diagnostics Inc
SQI Diagnostics Inc. (多伦多，Toronto)是专精于发展实验室级生物标识分子检测的医疗系统自动化的公司， 宣布公司已寄运一套Automated Multi–Biomarker SQiDworks(TM)多重生物标识分子自动化检测平台产品到美国Ohio州的Cleveland Clinic临床中心。这个研究中心的实验室是公司第二个在外部通过验证，而取得这个检测平台运作资格的伙伴。公司将评估这套系统在配合使用SQI Diagnostics' QuantiSpot(TM) RA assay检测时，其在分析能力方面之表现。公司也将利用该系统所得到的数据来作为法规申请的基础文件。公司的执行长Claude Ricks先生指出，一旦公司的科技平台可以在美国尖端的医院中进行效能验证，对公司而言，这己经是重要的科技成就。同时，这也证明这些医院有意愿在进行大量多重生物标识分子检测分析时，可以拥有突破性科技来节省时间和金钱。公司期待在2008上半年内可以完成验证测试，之后并可以将这些数据结果用于支持法规审核申请案

SQI's proprietary technologies enable Confidence, Profit and Growth for leading diagnostic laboratories that perform autoimmune testing. We provide laboratories the ability to simultaneously analyze multiple biomarkers, deliver accurate and quantitative patient results in less time, significantly reduce labor and increase profits...All in One Drop.

The company is focused on improving the confidence and profitability of laboratory diagnostic testing. Our first product on the SQiDworks™ Diagnostics Platform is the QuantiSpot™ Assay. This was developed to improve the accuracy of diagnosis of Rheumatoid Arthritis and increase the quality of information that is provided to the physician so they can optimize treatment decisions for each patient.

Thank you for taking a few minutes to explore our website and to learn more about SQI's revolutionary in-vitro multiplexing diagnostic testing. We look forward to the opportunity to meet you and share the full capabilities and benefits we can deliver to your business.